Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $173.00K in the quarter ending September 30, 2024, with 58.72% growth. This brings the company's revenue in the last twelve months to $631.70K, up 113.21% year-over-year. In the year 2023, Ovid Therapeutics had annual revenue of $391.70K, down -73.93%.

• Revenue (ttm): $631.70K
• Revenue Growth: +113.21%
• P/S Ratio: 116.61
• Revenue / Employee: $15,792
• Employees: 40
• Market Cap: 74.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	391.70K	-1.11M	-73.93%
Dec 31, 2022	1.50M	-206.88M	-99.28%
Dec 31, 2021	208.38M	195.77M	1,551.57%
Dec 31, 2020	12.62M	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.